ArticleTherapeutics and clinical risk management2016

Reduction of group A beta-hemolytic streptococcus pharyngo-tonsillar infections associated with use of the oral probiotic Streptococcus salivarius K12: a retrospective observational study.

Giuseppe Gregori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.